Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06252948 · ClinicalTrials.gov registry record
Gut Microbiome Studies in Patients With POEMS Syndrome and Other Plasma Cell Disorders
A clinical trial of Plasma Cell Disorders, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 240
- Enrollment target
- 1
- Study location
NCT06252948: Recruiting study of Plasma Cell Disorders, sponsored by Mayo Clinic.
NCT06252948 is a study of Plasma Cell Disorders that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 240 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06252948, a study of Plasma Cell Disorders, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
A Study to Evaluate Gut Microbiome with POEMS Syndrome and Other Plasma Cell Disorders
Primary Outcome
Stool samples will be collected by the patient using a stool self- collection kit provided to the participant by the study staff. Samples will be evaluated for characteristics of gut microbiome (α-diversity and β-diversity).
Conditions Studied
Interventions
- OTHER Non-interventional study (observational)
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2021-12-29 |
| Est. Completion | 2028-12-29 |
What NCT06252948 shows while recruiting
NCT06252948 is an observational study that tracks outcomes without assigning an intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Plasma Cell Disorders appearing as the primary indexed condition, and to 1 intervention - of which Non-interventional study (observational) is the first listed.
NCT06252948 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06252948 about?
NCT06252948 is a clinical study titled "Gut Microbiome Studies in Patients With POEMS Syndrome and Other Plasma Cell Disorders". A Study to Evaluate Gut Microbiome with POEMS Syndrome and Other Plasma Cell Disorders
What is the current status of trial NCT06252948?
This trial is currently recruiting. The enrollment target is 240 participants. The study started on 2021-12-29. Estimated completion is 2028-12-29.
What conditions does trial NCT06252948 study?
This clinical trial studies the following conditions: Plasma Cell Disorders.
What interventions are being tested in trial NCT06252948?
The interventions under investigation include: Non-interventional study (observational) (OTHER).
Who is sponsoring clinical trial NCT06252948?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06252948 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Plasma Cell Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI